{
  "ptid_time": "135_S_4598_2012-03-20",
  "img_path": "/data/qiuhui/data/adni/images/135_S_4598/2012-03-20/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 25,063 mm³, 12.2% above the reference mean. With a Z-score of 0.31 (62.0th percentile), this represents normal volume ; whole brain volume measures 1,100,010 mm³, 6.9% above the reference mean. With a Z-score of 0.86 (80.4th percentile), this represents normal volume ; entorhinal cortex volume measures 3,165 mm³, 18.7% below the reference mean. With a Z-score of -1.45 (7.4th percentile), this represents mild atrophy; fusiform gyrus volume measures 20,240 mm³, 11.1% above the reference mean. With a Z-score of 1.26 (89.5th percentile), this represents mild enlargement; middle temporal gyrus volume measures 26,866 mm³, 30.9% above the reference mean. With a Z-score of 2.75 (99.7th percentile), this represents significant enlargement. ",
  "text_data": "Age is 65.1 years. Gender is Female. Education: 20 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Cardiovascular; Respiratory; Endocrine-Metabolic. MMSE: 30.0. MoCA: 28.0. Logical Memory: 14.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.08 SUVR (normal ); Total tau: 348.50 pg/mL (mild elevated); Phosphorylated tau: 29.77 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The entorhinal cortex shows mild atrophy (Z-score -1.45, 7.4th percentile), which is a key early marker of Alzheimer's pathology. However, cognitive scores (MMSE 30, MoCA 28) are intact, and other brain regions (whole brain, fusiform gyrus, middle temporal gyrus) show normal or even enlarged volumes. Mildly elevated T-tau and P-tau suggest possible early neurodegenerative changes, but AV45 (amyloid PET) is normal, reducing the likelihood of amyloid-driven Alzheimer’s.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (Cognitive scores are normal, but entorhinal atrophy and tau elevation raise concern for early neurodegeneration; amyloid negativity complicates a clear Alzheimer’s diagnosis.)",
  "timestamp": "2025-07-26T15:38:33.450731"
}